Lindsay Kilburn

9PUBLICATIONS
69CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Infant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 22, 2026
Author Correction: Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial.

|Jul 01, 2026
Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial.

|Apr 16, 2025
Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.

Lindsay B Kilburn, Dong-Anh Khuong-Quang, Jordan R Hansford

|Mar 12, 2024
Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.

Lindsay B Kilburn, Dong-Anh Khuong-Quang, Jordan R Hansford

|Feb 09, 2024
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma.

Isabel Arrillaga-Romany, Sharon L Gardner, Yazmin Odia

|Nov 18, 2023
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.

Lindsay B Kilburn, Dong-Anh Khuong-Quang, Jordan R Hansford

Pageof 2

Frequent Collaborators

4 joint publications

Cassie Kline

3 joint publications

Darren Hargrave

3 joint publications

Dong-Anh Khuong-Quang

3 joint publications

Jordan R Hansford